[{"Assets_0_Q1_USD":629723000.0,"CommonStockSharesOutstanding_0_Q1_shares":20996049.0,"EarningsPerShareBasic_1_Q1_USD":0.24,"EarningsPerShareDiluted_1_Q1_USD":0.22,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":24222000.0,"NetIncomeLoss_1_Q1_USD":5079000.0,"StockholdersEquity_0_Q1_USD":371830000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":23019189.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":20938000.0,"Ticker":"LGND","CIK":"886163","name":"LIGAND PHARMACEUTICALS INC","OfficialName":"Ligand Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1738856427.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170509"}]